Profile
SpringRock Ventures is a venture capital firm based in Seattle, Washington. Founded with the perspective that healthcare and information technology are converging, the firm focuses on investing in the next cycle of healthcare innovation. The managing directors, Eric Bell and Kirsten Morbeck, have extensive backgrounds in healthcare and technology, with a history of successful investments and entrepreneurial experience. The team prides itself on helping entrepreneurs by providing strategic guidance and fostering a collaborative relationship.
SpringRock Ventures primarily invests in digital health, devices, services, oral health, SAAS, consumerization of healthcare, IT, and wellness. They invest in early to late stage companies in North America with high growth potential. The firm typically invests between $2 million to $5 million in these companies and also engages in seed/EIR stage investments specifically in oral health.
The firm has a notable portfolio including companies like C-SATS - medical feedback solution, Vascular Solutions - vascular device provider, Illumina - genomics services, Rosetta Pharmaceuticals - therapeutics, and Aquantive - digital marketing. These investments reflect SpringRock's commitment to supporting innovative healthcare solutions.
Industry
SpringRock Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
SpringRock Venture Partners V
|
Venture Capital (VC)
|
Media and Entertainment
Software
Transportation
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$650 M
|
February 2025
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.